Use of dynamic contrast-enhanced MRI to measure subtle blood-brain barrier abnormalities.
Armitage
Paul A
PA
Clinical Neurosciences, School of Molecular and Clinical Medicine, Western General Hospital, University of Edinburgh, Edinburgh, EH4 2XU, Scotland, UK. paul.armitage@ed.ac.uk
Farrall
Andrew J
AJ
Carpenter
Trevor K
TK
Doubal
Fergus N
FN
Wardlaw
Joanna M
JM
D000368:Aged; D001812:Blood-Brain Barrier / Q000473:pathology*; D003287:Contrast Media; D019786:Gadolinium DTPA; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D009413:Nerve Fibers, Myelinated / Q000473:pathology*; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D020521:Stroke / Q000473:pathology*
D003287:Contrast Media; C064925:gadodiamide; D019786:Gadolinium DTPA